In order to confirm the involvement of histone modifications in miR-212 silencing in NSCLC, we inhibited both EZH2 expression and HDAC activity and then analyzed the effects on miR-212 expression in Calu-1 cells. This evidence concerns the gene EZH2 and non-small cell lung carcinoma.